Clinical Trials
29 trialsA Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
Pfizer
RISE
Gruppo Italiano Malattie EMatologiche dell'Adulto
COGNITOX
University of Aarhus
MARINA
iOMEDICO AG
REMAKE
The Royal Wolverhampton Hospitals NHS Trust
MMExFFPE
BIWAKO
MM-t4-14-FFPE
BIWAKO
Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
QOL-ONE PRO-CT
Associazione Qol-one
MITOX
IRCCS San Raffaele
Risk-adapted Therapeutic Strategy in +1q NDMM
The First Hospital of Jilin University
Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
Shanghai East Hospital
GAMY
University Hospital, Rouen
Multi-center Screening for Serum M Protein
Zhujiang Hospital
MMOMICS
Tel-Aviv Sourasky Medical Center
Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy
CARsgen Therapeutics Co., Ltd.
5p15/ 9q22/ 15q22 Hyperdiploidy and Their Significance in Multiple Myeloma Patients
Assiut University
A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma
CARsgen Therapeutics Co., Ltd.
PC002
Leuko Labs, Inc.
BiMM
University Medical Center Groningen
Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
Assiut University
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
Peking University People's Hospital
genetics MM
Siriraj Hospital
Haplo
Siriraj Hospital
Registry PCD
Siriraj Hospital
Examination of Trends in Multiple Myeloma Trial Patient Experiences
Power Life Sciences Inc.
DECIMA
Guy's and St Thomas' NHS Foundation Trust
GEN-HEMO-INF
Assistance Publique - Hôpitaux de Paris
Detection and Pathogenesis of Novel Protein F
Wuhan Asia Heart Hospital